Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis'
October 15, 2024 | 20:00
Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its collaboration with AriBio, a biopharmaceutical company developing therapies for neurodegenerative diseases, to develop next-generation platform for Alzheimer's diagnosis.
Mobile Version